SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 127 filers reported holding SANGAMO THERAPEUTICS INC in Q4 2016. The put-call ratio across all filers is 0.69 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $124,000 | -15.6% | 14,061 | -55.6% | 0.00% | 0.0% |
| Q3 2016 | $147,000 | -28.3% | 31,653 | -6.4% | 0.00% | -50.0% |
| Q1 2016 | $205,000 | +19.9% | 33,810 | +80.4% | 0.01% | +100.0% |
| Q4 2015 | $171,000 | +2.4% | 18,739 | -36.7% | 0.00% | 0.0% |
| Q3 2015 | $167,000 | -4.0% | 29,591 | +166.0% | 0.00% | -25.0% |
| Q1 2015 | $174,000 | -43.0% | 11,123 | -60.7% | 0.00% | -33.3% |
| Q3 2014 | $305,000 | +37.4% | 28,302 | +94.7% | 0.01% | +100.0% |
| Q2 2014 | $222,000 | -66.2% | 14,536 | -60.0% | 0.00% | -62.5% |
| Q1 2014 | $657,000 | – | 36,352 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FIC CAPITAL INC | 875,284 | $2,670,000 | 1.34% |
| NEXTHERA CAPITAL LP | 503,000 | $1,534,000 | 0.90% |
| Opaleye Management Inc. | 400,000 | $1,220,000 | 0.72% |
| WASATCH ADVISORS LP | 7,256,260 | $22,132,000 | 0.33% |
| Cormorant Asset Management, LP | 650,000 | $1,983,000 | 0.27% |
| Sicart Associates LLC | 101,950 | $311,000 | 0.22% |
| Baker Brothers Advisors | 4,055,876 | $12,370,000 | 0.12% |
| Leisure Capital Management | 43,008 | $131,000 | 0.12% |
| Piermont Capital Management Inc. | 165,569 | $505,000 | 0.12% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 837,963 | $2,556,000 | 0.10% |